Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Medtech Matters

Medtech Matters artwork

Predetermined Change Control Plans, Part 1

Sep 24, 202448 minAudio
ShareXLinkedInFacebookWhatsAppEmail

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we examine the FDA’s recent guidance documents regarding predetermined change control plans (PCCP). The first guidance addresses PCCPs for artificial intelligence (AI) and/or machine learning (ML) based devices (click here to hear an earlier podcast on this topic). The more recent guidance expands the scope to any medical device, whether it has AI/ML or not. Specifically, the following questions are addressed: What is a predetermined change control plan and why is it important? FDA published two guidances on PCCPs (one last year in April and one just this past August). These two guidances sound similar (maybe substantially equivalent), so what’s the difference? What’s the difference between a PCCP for a SaMD with ML or AI different from a PCCP for a non-SaMD device, like a catheter or stent? Are there any limits on changes in a PCCP? How and when do I submit a PCCP? What are the advantages of submitting a PCCP? Are there any disadvantages of submitting a PCCP? Listen to part 2 of this discussion and then see if you have a better understanding of PCCPs. If you’d like to share thoughts, ask questions, or have a suggestion for a future topic for us to cover, please reach out to me at sfenske@rodmanmedia.com and we’ll see if we want to address your ideas/inquiries/suggestions in a future episode. Send us Fan Mail For more medtech news and information, visit https://www.mpomag.com.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. An Early Look at FDA’s Guidance Focus for 2027, Part 2

    Nov 2, 20261 hr 2 minAudio

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re continuing the conversation of guidance documents that are expected to gain the attention of the agency...

    Credit the people on this episode

  2. An Early Look at FDA’s Guidance Focus for 2027, Part 1

    Nov 2, 202647 minAudio

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we review the list of guidances FDA expects to begin to focus on in 2027. The list really represents the...

    Credit the people on this episode

  3. A Preview of MDUFA VI: Changes and Highlights, Part 2

    Sep 11, 202650 minAudio

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re into part 2 of the discussion in an early look at the next Medical Device User Fee Act, MDUFA VI, which...

    Credit the people on this episode

  4. A Preview of MDUFA VI: Changes and Highlights, Part 1

    Sep 11, 202648 minAudio

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re taking an early look at the next version of the Medical Device User Fee Act, MDUFA VI, which would go...

    Credit the people on this episode

  5. The Value in Partnering for Sterility Testing

    Sep 9, 202626 minAudio

    In this Medtech Matters podcast episode, sponsored by Nelson Labs, two representatives from the company offer their expertise and insights on sterility testing. Amina Rahmoune, Laboratory Operations Manager - Sterility...

    Credit the people on this episode